Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Aug;33(8):1984–1988. doi: 10.1128/jcm.33.8.1984-1988.1995

Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

A el Harith 1, S Chowdhury 1, A al-Masum 1, S Semião-Santos 1, E Karim 1, S el-Safi 1, I Haque 1
PMCID: PMC228321  PMID: 7559934

Abstract

Trypsin treatment of Leishmania promastigote antigen has proved to be indispensible in the direct agglutination test (DAT) for the diagnosis of visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL). In the present study four antigen batches were prepared with pronase (400 micrograms/ml), lipase (0.45% [wt/vol]), pancreatin (0.3% [wt/vol]), or 2-mercaptoethanol (2-ME) (1.2% [vol/vol]) at a ratio of 20:1 versus promastigote packed cell volume or a density of 10(8)/ml. Batches prepared in this way performed satisfactorily when compared with the performance of the initial trypsinated antigen. Even higher was the sensitivity and specificity of the 2-ME-processed antigen, scoring a minimum DAT titer of 1:102,400 in the VL and CVL group and a maximum of 1:400 in the negative control group. Corresponding titers ranging from 1:6,400 to 1:12,800 and 1:800 to 1:1,600 were obtained with the antigen variants processed with pronase, lipase, pancreatin, or trypsin. By combining the use of indigenous Leishmania donovani subspecies from Sudan, Bangladesh, or Morocco and incorporating 2-ME instead of trypsin in the antigen processing step, a threefold increase in titer was attained in sera from the respective areas where VL is endemic. 2-ME-processed antigen suspensions maintained stability at 4 degrees C for up to 9 months, as evidenced by the absence of autoagglutination and the reproducibility of DAT readings with standard sera. The specificity of DAT was further improved by supplementation of the sample diluent with 0.03 M urea and incubation of the test plates at 37 degrees C for 1 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (269.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade C. R., Silva O. A., Andrade P. P., Kolk A. H., Harith A. E. A direct agglutination test discriminative toward Chagas' disease for the diagnosis of visceral leishmaniasis in Brazil: preliminary results. Ann Inst Pasteur Immunol. 1987 May-Jun;138(3):457–459. doi: 10.1016/s0769-2625(87)80056-9. [DOI] [PubMed] [Google Scholar]
  2. Auxiliadora M., Santos M., de Andrade P. P., de Andrade C. R., Padovan P. A., de Souza W. Effect of trypsin and 2-mercaptoethanol on the exposure of sugar residues on the surface of Leishmania donovani chagasi. Parasitol Res. 1991;77(7):553–557. doi: 10.1007/BF00931011. [DOI] [PubMed] [Google Scholar]
  3. Bouvier J., Etges R. J., Bordier C. Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes. J Biol Chem. 1985 Dec 15;260(29):15504–15509. [PubMed] [Google Scholar]
  4. Chowdhury M. S., el Harith A., al Massum A., al Karim E., al Rahman A. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities. Parasitol Res. 1993;79(6):444–450. doi: 10.1007/BF00931580. [DOI] [PubMed] [Google Scholar]
  5. Hailu A. Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):673–675. doi: 10.1016/0035-9203(90)90141-z. [DOI] [PubMed] [Google Scholar]
  6. Harith A. E., Kolk A. H., Kager P. A., Leeuwenburg J., Faber F. J., Muigai R., Kiugu S., Laarman J. J. Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Trans R Soc Trop Med Hyg. 1987;81(4):603–606. doi: 10.1016/0035-9203(87)90423-8. [DOI] [PubMed] [Google Scholar]
  7. Karp C. L., Turco S. J., Sacks D. L. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. J Immunol. 1991 Jul 15;147(2):680–684. [PubMed] [Google Scholar]
  8. Okong'o-Odera E. A., Wamachi A., Kagai J. M., Kurtzhals J. A., Githure J. I., Hey A. S., Were J. B., Koech D. K., Mitema E. S., Kharazmi A. Field application of an ELISA using redefined Leishmania antigens for the detection of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):423–424. doi: 10.1016/0035-9203(93)90023-j. [DOI] [PubMed] [Google Scholar]
  9. Reed S. G., Badaro R., Lloyd R. M. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J Immunol. 1987 Mar 1;138(5):1596–1601. [PubMed] [Google Scholar]
  10. Seaman J., Ashford R. W., Schorscher J., Dereure J. Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditions. Ann Trop Med Parasitol. 1992 Oct;86(5):481–486. doi: 10.1080/00034983.1992.11812697. [DOI] [PubMed] [Google Scholar]
  11. Shreffler W. G., Burns J. M., Jr, Badaró R., Ghalib H. W., Button L. L., McMaster W. R., Reed S. G. Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis. 1993 Feb;167(2):426–430. doi: 10.1093/infdis/167.2.426. [DOI] [PubMed] [Google Scholar]
  12. Tebourski F., el Gaied A., Louzir H., Ben Ismail R., Kammoun R., Dellagi K. Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis. J Clin Microbiol. 1994 Oct;32(10):2474–2480. doi: 10.1128/jcm.32.10.2474-2480.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. de Korte P. M., Harith A. E., Dereure J., Huigen E., Faucherre V., van der Kaay H. J. Introduction of an improved direct agglutination test for the detection of Leishmania infantum infection in southern France. Parasitol Res. 1990;76(6):526–530. doi: 10.1007/BF00931059. [DOI] [PubMed] [Google Scholar]
  14. el Harith A., Kolk A. H., Leeuwenburg J., Muigai R., Huigen E., Jelsma T., Kager P. A. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol. 1988 Jul;26(7):1321–1325. doi: 10.1128/jcm.26.7.1321-1325.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. el Harith A., Laarman J. J., Minter-Goedbloed E., Kager P. A., Kolk A. H. Trypsin-treated and coomassie blue-stained epimastigote antigen in a microagglutination test for Chagas' disease. Am J Trop Med Hyg. 1987 Jul;37(1):66–71. doi: 10.4269/ajtmh.1987.37.66. [DOI] [PubMed] [Google Scholar]
  16. el Harith A., Slappendel R. J., Reiter I., van Knapen F., de Korte P., Huigen E., Kolk A. H. Application of a direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir. J Clin Microbiol. 1989 Oct;27(10):2252–2257. doi: 10.1128/jcm.27.10.2252-2257.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. el Safi S. H., Evans D. A. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):334–337. doi: 10.1016/0035-9203(89)90493-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES